✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Amgen Inc

Common Name
Amgen
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
31,500
Ticker
AMGN
Exchange
Nasdaq
Description
Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on innovative medicines addressing serious illnesses in areas such a...

Amgen's Waste Data Preview

In 2025, Amgen conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2025202420232022-2019
Total Waste Generated
46,541a
20,717a
13,871a
Total Waste Recovered
N/AN/AN/A
Total Hazardous Waste Generated
2,019a
1,783a
1,716a
Non-Hazardous Waste Disposed
2,190a
1,938a
1,505a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Amgen’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Amgen's ESG Data Spreadsheet 2025

Insights into Amgen’s Generation of Hazardous and Non-Hazardous Waste

In 2025, Amgen generated a total of 46,541 metric tonnes of waste.a

Of this amount, 4.34% of Amgen's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.22.84% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.The remaining 72.83% was either treated using unspecified methods or not clearly categorized.a

Amgen’s Hazardous vs Non-Hazardous Waste Over Time

201920202021202220232024202503.5 k7 k10.5 k14 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Amgen reduced the environmental impact of its waste?

Since 2019, Amgen's total waste generation increased by 259.5%, including a 124.65% rise in 2025, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.a

Over the same period, Amgen reduced the hazardousness of its waste by 74.23%, with a further 49.59% decline in 2025, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.a

Overall, Amgen is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment.a

How does Amgen treat its hazardous waste?

In 2025, Amgen reported that 2,019 metric tonnes of its total waste output were classified as hazardous. This represents 4.34% of its overall waste generation.a

The company treated this hazardous waste using a combination of methods.A majority (77.27%) was diverted from disposal through recovery-oriented treatments such as recycling or reuse. This suggests that Amgen has established processes to reduce the environmental burden of its most harmful waste streams.a

Breakdown of Amgen's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteRecovered(12.3%)Non-Hazardous WasteDisposed(17.3%)Non-Hazardous WasteRecovered(66.7%)
Want Full Access to Amgen's Waste Management Dataset?
Start 30-Day Free Trial